The “Environmental Impact Report for the Anti-cancer Drug PENAO Project and Cell R&D and Transformation Project” (hereinafter referred to as the “Project”) submitted by the subsidiary of Beroni Group, Beroni…
On September 8th, 2023, the “4th World-Class Enterprises R&D and Innovation Management Forum” was successfully held in Huabei Hotel, Hangzhou. Mr. Qingrui Xu, Academician of Chinese Academy of Engineering, Director…
On 24th July, the second plenary session of the first members’ conference of the Federation of Entrepreneurs Tianjin was held in the Tianjin Auditorium. Mr. Jacky Zhang, Executive Chairman of…
On March 31st, the signing ceremony of a Practice Base Agreement between Tianjin Beroni Biotechnology Co., Ltd., a subsidiary of Beroni Group and Shenyang University of Chemical Technology was held…
On February 8, 2023, Beroni Group Limited (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, announced that its enhanced COVID-19 Antigen Rapid Test Kit - Colloidal Gold Method has…
The award site of Beroni Pharmaceutical (Guangdong) Co., Ltd. On December 19, 2022, the finals of the 8th “Jingniuhui” Venture Competition of Zhuhai Hi-tech Zone was launched in Zhuhai Hi-tech…
On November 5, 2022, Beroni Group was invited to participate in the “Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association”, which was sponsored…
On August 28, 2022, the first “Industry, University Research and Application, Innovative Medicine” Summit Forum ((hereinafter referred to as the “Forum”)) and the inaugural meeting of Tianjin Biomedical Discipline Innovation…
Beroni Announces Beilemei’s Brand Endorser—Dan Zhu, World Champion in Rhythmic Gymnastics On July 10, 2022, Beroni Group signed agreement with Dan Zhu, world champion in rhythmic gymnastics to invite her…
